Medical Properties Trust Inc. MPT
Real Estate Investment Trusts · data as of November 13, 2026
Medical Properties Trust Inc. (MPT) is a real estate company listed in the US with a market value of about $983M. In the twelve months to September 30, 2026 it had revenue of $1.0B and net income of $248M, a net margin of 24.0%.
Its overall Stock Analiz score is 2.0 out of 5 (weak). The strongest part is value (4/5); the weakest is track record (0/5).
Key numbers: a P/E of 4.0, a price to free cash flow of 3.9, 5-year revenue growth of -5% a year, a 5-year average ROIC of 1%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 276% above the current price.
About Medical Properties Trust
Medical Properties Trust is listed in the US and classified in real estate investment trusts. Revenue went from $313M in 2014 to $972M in 2025, growth of about 10.9% a year. It was profitable in 7 of the last 10 years in our data.
Score: 2.0 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- Profit margin improving
- Positive free cash flow
- Pays a dividend
- 20% to 100% of free cash flow returned to shareholders
Checks not passed
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $972M | $996M | $872M | $1.5B | $1.5B | $1.2B | $854M | $785M | $705M | $541M |
| Net income | $248M | -$277M | -$2.4B | -$556M | $903M | $656M | $431M | $375M | $1.0B | $290M | $225M |
| Free cash flow | $249M | $89M | $140M | $271M | -$594M | -$4.5B | -$3.6B | -$4.1B | -$982M | -$1.9B | -$1.4B |
| EPS (diluted) | $0.41 | $-0.46 | $-4.02 | $-0.93 | $1.50 | $1.11 | $0.81 | $0.87 | $2.76 | $0.82 | $0.86 |
| Net margin | 24.0% | -28.5% | -242.1% | -63.8% | 58.5% | 42.5% | 34.5% | 43.9% | 129.6% | 41.1% | 41.6% |
| ROIC | — | 0.2% | -0.2% | -1.5% | 3.2% | 3.0% | 2.9% | 1.9% | 3.9% | 5.5% | 4.4% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 5 analysts is $3.55, 113% above the current price; targets range from $2.00 to $5.00; the consensus rating is “Hold”; expected EPS is $0.34 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Medical Properties Trust’s P/E ratio?
About 4.0, based on the last twelve months of diluted earnings per share.
Is Medical Properties Trust stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 276% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Medical Properties Trust pay a dividend?
Yes. The dividend yield is about 21.56%, and it has paid dividends for 10 years in our data.
Is Medical Properties Trust a good stock to buy?
We do not give buy or sell advice. Medical Properties Trust scores 2.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.